AHA 2017 The TNT-POAF study evaluated botulinum toxin as a way to modulate autonomous nervous system tone, to reduce post-operative AF. Time to first episode of AF and the incidence of POAF were numerically lower, but no significant improvements were seen.
This 3-minute education provides a summary of just presented scientific data, recorded during the AHA 2017 congress. The objective is to provide a brief commentary and potential implications of these findings.
Nathan Waldron, MD is an adult cardiothoracic anesthesiologist at Duke University Medical Center, Durham, NC, USA.The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
- AHA 2017Positive lesson from a negative trial comparing peri-operative continuation or interruption of DOAC therapy
David H. Birnie, MD